These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 22904106)
21. GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms. Tepper CG; Vinall RL; Wee CB; Xue L; Shi XB; Burich R; Mack PC; de Vere White RW Prostate; 2007 Apr; 67(5):521-35. PubMed ID: 17252539 [TBL] [Abstract][Full Text] [Related]
22. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1. Zaia A; Fraizer GC; Piantanelli L; Saunders GF Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720 [TBL] [Abstract][Full Text] [Related]
23. HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes. Axlund SD; Lambert JR; Nordeen SK Mol Cancer Res; 2010 Dec; 8(12):1643-55. PubMed ID: 21047772 [TBL] [Abstract][Full Text] [Related]
24. Nkx3.1 and p27(KIP1) cooperate in proliferation inhibition and apoptosis induction in human androgen-independent prostate cancer cells. Wang P; Ma Q; Luo J; Liu B; Tan F; Zhang Z; Chen Z Cancer Invest; 2009 May; 27(4):369-75. PubMed ID: 19266349 [TBL] [Abstract][Full Text] [Related]
25. Prostate cancer cells increase androgen sensitivity by increase in nuclear androgen receptor and androgen receptor coactivators; a possible mechanism of hormone-resistance of prostate cancer cells. Fujimoto N; Miyamoto H; Mizokami A; Harada S; Nomura M; Ueta Y; Sasaguri T; Matsumoto T Cancer Invest; 2007 Feb; 25(1):32-7. PubMed ID: 17364555 [TBL] [Abstract][Full Text] [Related]
27. Development of an androgen-deprivation induced and androgen suppressed human prostate cancer cell line. Lee SO; Dutt SS; Nadiminty N; Pinder E; Liao H; Gao AC Prostate; 2007 Sep; 67(12):1293-300. PubMed ID: 17626246 [TBL] [Abstract][Full Text] [Related]
28. c-Jun enhancement of androgen receptor transactivation is associated with prostate cancer cell proliferation. Chen SY; Cai C; Fisher CJ; Zheng Z; Omwancha J; Hsieh CL; Shemshedini L Oncogene; 2006 Nov; 25(54):7212-23. PubMed ID: 16732317 [TBL] [Abstract][Full Text] [Related]
29. Prosaposin upregulates AR and PSA expression and activity in prostate cancer cells (LNCaP). Koochekpour S; Lee TJ; Wang R; Culig Z; Delorme N; Caffey S; Marrero L; Aguirre J Prostate; 2007 Feb; 67(2):178-89. PubMed ID: 17044040 [TBL] [Abstract][Full Text] [Related]
30. Induction of AP-1 activity by androgen activation of the androgen receptor in LNCaP human prostate carcinoma cells. Church DR; Lee E; Thompson TA; Basu HS; Ripple MO; Ariazi EA; Wilding G Prostate; 2005 May; 63(2):155-68. PubMed ID: 15486991 [TBL] [Abstract][Full Text] [Related]
31. Androgen regulation of the prostatic tumour suppressor NKX3.1 is mediated by its 3' untranslated region. Thomas MA; Preece DM; Bentel JM Biochem J; 2010 Jan; 425(3):575-83. PubMed ID: 19886863 [TBL] [Abstract][Full Text] [Related]
32. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer. Zerbini LF; Wang Y; Cho JY; Libermann TA Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841 [TBL] [Abstract][Full Text] [Related]
34. Androgens and estrogens stimulate ribosome biogenesis in prostate and breast cancer cells in receptor dependent manner. Ray S; Johnston R; Campbell DC; Nugent S; McDade SS; Waugh D; Panov KI Gene; 2013 Aug; 526(1):46-53. PubMed ID: 23608168 [TBL] [Abstract][Full Text] [Related]
35. SMYD3 as an oncogenic driver in prostate cancer by stimulation of androgen receptor transcription. Liu C; Wang C; Wang K; Liu L; Shen Q; Yan K; Sun X; Chen J; Liu J; Ren H; Liu H; Xu Z; Hu S; Xu D; Fan Y J Natl Cancer Inst; 2013 Nov; 105(22):1719-28. PubMed ID: 24174655 [TBL] [Abstract][Full Text] [Related]
36. Involvement of arginine methyltransferase CARM1 in androgen receptor function and prostate cancer cell viability. Majumder S; Liu Y; Ford OH; Mohler JL; Whang YE Prostate; 2006 Sep; 66(12):1292-301. PubMed ID: 16705743 [TBL] [Abstract][Full Text] [Related]
37. Cav1.3 channel α1D protein is overexpressed and modulates androgen receptor transactivation in prostate cancers. Chen R; Zeng X; Zhang R; Huang J; Kuang X; Yang J; Liu J; Tawfik O; Thrasher JB; Li B Urol Oncol; 2014 Jul; 32(5):524-36. PubMed ID: 24054868 [TBL] [Abstract][Full Text] [Related]
38. Pim1 regulates androgen-dependent survival signaling in prostate cancer cells. van der Poel HG; Zevenhoven J; Bergman AM Urol Int; 2010; 84(2):212-20. PubMed ID: 20215828 [TBL] [Abstract][Full Text] [Related]
39. Transcriptional network of androgen receptor in prostate cancer progression. Takayama K; Inoue S Int J Urol; 2013 Aug; 20(8):756-68. PubMed ID: 23600948 [TBL] [Abstract][Full Text] [Related]
40. PTTG1, A novel androgen responsive gene is required for androgen-induced prostate cancer cell growth and invasion. Zhang Z; Jin B; Jin Y; Huang S; Niu X; Mao Z; Xin D Exp Cell Res; 2017 Jan; 350(1):1-8. PubMed ID: 27756608 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]